ADC Therapeutics
ADCT
ADCT
37 hedge funds and large institutions have $57.7M invested in ADC Therapeutics in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Holders
37
Holding in Top 10
2
Calls
–
Puts
$3K
Top Buyers
| 1 | +$1.91M | |
| 2 | +$1.78M | |
| 3 | +$1.49M | |
| 4 |
Goldman Sachs
New York
|
+$675K |
| 5 |
Jane Street
New York
|
+$168K |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$1.73M | |
| 3 | -$1.48M | |
| 4 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
-$958K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$692K |